Overview
Oxbridge Re Q3 net premiums earned decreased due to lower reinsurance contract rates
Net loss for Q3 decreased due to lower unrealized losses on investments
Total expenses for Q3 increased due to higher professional and operational costs
Outlook
Oxbridge Re plans to introduce regular dividend payouts on CatRe tokens
Company's Balanced Yield Token exceeds 20% target, tracking approximately 25%
High Yield Token remains on track to meet 42% target
Result Drivers
EXPENSE INCREASE - Total expenses rose due to increased professional and operational costs, including Web3 subsidiary and legal expenditures
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Combined Ratio | 146.80% | ||
Q3 Expense Ratio | 146.80% |
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the reinsurance peer group is "buy"
Wall Street's median 12-month price target for Oxbridge Re Holdings Ltd is $5.00, about 71.9% above its November 5 closing price of $1.41
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)